
Please try another search
ImpediMed Limited, a medical technology company, manufactures, and sells bioimpedance spectroscopy (BIS) technology medical devices in the Unites States and Europe. The company offers SOZO, a noninvasive BIS device for the clinical assessment of lymphedema and deliver snapshot of fluid status and tissue composition; L-Dex analysis for lymphedema; BodyComp Analysis, a point-of-car body composition analysis; and HF-Dex analysis for point-or care heart failure fluid assessment. It also provides SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. The company was incorporated in 1999 and is headquartered in Carlsbad, California with additional office in Lindfield, Australia.
Name | Age | Since | Title |
---|---|---|---|
Christine Emmanuel-Donnelly | - | 2023 | Independent Non-Executive Chair |
Janelle Delaney | - | 2023 | Independent Non-Executive Director |
Parmjot Bains | - | 2024 | MD, CEO & Director |
McGregor Grant | - | 2023 | CFO & Executive Director |
Fiona Bones | - | 2024 | Non-Executive Director |
Andrew Grant | - | 2023 | Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review